NORTHAMPTON, MA / ACCESS Newswire / May 16, 2025 / Picture this: You open your medicine cabinet and find a bottle of expired pills ... health risks. Boehringer Ingelheim Taiwan launched an ...

Global pharmaceutical giant Boehringer Ingelheim has signed a new five-year ... The firm develops and markets products for both human and animal health. OMD’s remit includes human and animal ...

Poultry vaccines are available to producers who need to control  Bronchitis, Bursal Disease, Encephalitis, Fowl Pox, Laryngotracheitis, Marek's Disease, ...

The global veterinary dermatology market, valued at US$18.59 billion in 2024, is forecasted to grow at a robust CAGR of 8.5%, ...

NPPA sets retail prices for 41 drug combinations, including 18 variants of off-patent diabetes drug empagliflozin, following steep price drops post-patent expiry ...

Financial Stability: Eli Lilly's balance sheet is more robust, with debt making up only 4% of equity, considerably less than ...

King & Spalding still has about 175 products liability lawyers worldwide and another 130 specializing in toxic and ...

The large molecule drug substance CDMO market is anticipated to expand at a CAGR of ~9% during the forecast period. Key ...

The large molecule injectable drugs market is anticipated to expand at a CAGR of ~9% during the forecast period. Key drivers ...

Boehringer Ingelheim has taken an option on a family ... that spans both pharmacological and digital therapeutic (DTx) products. Leading the charge for new drug therapies is iclepertin (also ...

The 5th Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) will gather industry leaders in Vösendorf, Austria on 24-25 November for in‑depth case studies, practical workshops and ...